Kornitzer Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.15M	Buy	7,726 +1,120	+17%	+$323K	0.05%	297
2025 Q4	$2M	Sell	6,606 -3,010	-31%	-$939K	0.04%	324
2025 Q3	$2.7M	Sell	9,616 -725	-7%	-$197K	0.05%	290
2025 Q2	$2.5M	Sell	10,341 -27,933	-73%	-$6.6M	0.05%	302
2025 Q1	$9.32M	Sell	38,274 -1,029	-3%	-$310K	0.19%	138
2024 Q4	$12.9M	Buy	39,303 +786	+2%	+$267K	0.25%	107
2024 Q3	$12.9M	Buy	38,517 +3,564	+10%	+$1.13M	0.24%	127
2024 Q2	$9.55M	Buy	34,953 +100	+0.3%	+$29.1K	0.18%	163
2024 Q1	$12.1M	Sell	34,853 -1,794	-5%	-$590K	0.22%	137
2023 Q4	$11.8M	Sell	36,647 -4,048	-10%	-$1.27M	0.23%	132
2023 Q3	$14.6M	Hold	40,695	–	–	0.3%	93
2023 Q2	$15.4M	Sell	40,695 -5,000	-11%	-$2.03M	0.3%	93
2023 Q1	$21.9M	Buy	45,695 +4,635	+11%	+$2.17M	0.44%	54
2022 Q4	$17.3M	Buy	41,060 +16,257	+66%	+$6.56M	0.35%	78
2022 Q3	$10.3M	Sell	24,803 -1,107	-4%	-$552K	0.22%	154
2022 Q2	$12.8M	Hold	25,910	–	–	0.26%	131
2022 Q1	$14.6M	Hold	25,910	–	–	0.24%	139
2021 Q4	$19.6M	Hold	25,910	–	–	0.29%	116
2021 Q3	$19.3M	Sell	25,910 -630	-2%	-$472K	0.3%	120
2021 Q2	$17.1M	Hold	26,540	–	–	0.26%	155
2021 Q1	$15.2M	Hold	26,540	–	–	0.24%	162
2020 Q4	$15.5M	Sell	26,540 -1,400	-5%	-$797K	0.26%	138
2020 Q3	$14.4M	Sell	27,940 -17,585	-39%	-$8.91M	0.28%	134
2020 Q2	$20.6M	Sell	45,525 -11,387	-20%	-$5.03M	0.41%	76
2020 Q1	$20M	Buy	56,912 +49,422	+660%	+$18.2M	0.47%	58
2019 Q4	$2.77M	Sell	7,490 -1,236	-14%	-$436K	0.05%	305
2019 Q3	$2.9M	Buy	8,726 +750	+9%	+$245K	0.05%	303
2019 Q2	$2.49M	Buy	7,976 +1,990	+33%	+$596K	0.04%	313
2019 Q1	$1.83M	Buy	5,986 +1,771	+42%	+$478K	0.03%	326
2018 Q4	$979K	Buy	+4,215	New	+$1.13M	0.02%	383